We’re excited to share the successful completion of our first client project using the Olink Reveal™ workflow—a cutting-edge, cost-effective platform for profiling ~1,000 proteins with PEA-NGS technology. Ideal for pilot studies, Olink Reveal supports biomarker discovery, target identification, and deeper insights into disease detection and treatment response.
Read MoreIn a recent episode of the Speaking of Mol Bio podcast by Thermo Fisher Scientific, Dr Cath Moore, Chief Scientific Officer at AGRF, explores the impact of molecular biology technologies across various sectors in Australia. With over two decades of experience spanning academia and industry, Cath offers a unique perspective on the evolution of genomic tools and their real-world applications.
Read MoreAGRF is excited to announce the winners of our Free Lane of 10B Sequencing Giveaway, celebrating the impactful work of researchers across Australia using genomics to drive discovery.
Congratulations to Nigel Jackett from the School of the Environment, Research and Recovery of Endangered Species Group at The University of Queensland — the first winner of our sequencing giveaway.
Nigel’s research, in partnership with Owl Friendly Margaret River, is dedicated to the conservation of endangered species. Using AGRF’s Next Generation Sequencing (NGS) services, his work aims to generate the genomic insights needed to support meaningful and long-term conservation outcomes.
We’re excited to follow Nigel’s work and see how this data contributes to preserving Australia’s biodiversity.
Congratulations to Dr Huyen Phan, Project Leader and Senior Research Fellow at the Centre for Crop and Disease Management (CCDM), Curtin University.
Dr Phan leads critical research into septoria nodorum, a major wheat disease causing crop losses across Western Australia’s wheatbelt. Her work explores both the pathogenicity of the fungal agent and the genetic resistance mechanisms in wheat, supported by AGRF’s sequencing technologies.
“Sequencing is a crucial tool to help me answer many complicated biological questions. It provides the perfect complement to my wet lab experiments and reduces time and labour in our lab,” says Dr Phan.
We’re proud to support Dr Phan’s research and contribute to improving the resilience and productivity of Australian agriculture.
By simply requesting a quote for our NGS service, researchers were automatically entered to win a free lane of 10B sequencing on the NovaSeq X Plus, plus a 1-hour bioinformatics consultation with our expert team.
Our NGS service delivers high-quality, reliable data to power research across agriculture, conservation, medicine, and beyond.
Stay tuned for more opportunities and promotions from AGRF as we continue to support Australia’s research community through world-class genomics.
Polygenic Risk Scores (PRS) are transforming the way we predict, prevent, and manage common diseases like cancer, cardiovascular disease, and diabetes. By analysing thousands of genetic variants, PRS provides a powerful tool for identifying individuals at higher risk, enabling earlier interventions and more personalised healthcare strategies. Now, with the integration of Allelica PREDICT and AGRF’s high-quality genotyping services, researchers and clinicians have access to cutting-edge PRS analysis that strengthens primary care, enhances public health initiatives, and supports groundbreaking medical research.
Read MoreAn exciting partnership between AGRF (the Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities.
The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field.
Read MoreAGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s Advanced Genomics group to offer cutting-edge epigenetic services utilising EpiCypher’s CUT&RUN and CUT&Tag technologies.
Read MoreMedia Release
AGRF is thrilled to announce the expansion of its Olink® fleet with the addition of the Olink Signature Q100. Funded by The Kids Research Institute (The Kids) in Perth, the platform joins our certified Olink Explore HT and Explore 3072 workflows and will allow us to run the Olink Target 96 and 48 workflows, enabling researchers with both absolute and relative quantitative proteomic data, driving the identification and validation of biomarkers from early discovery to implementation and disease risk prediction.
Read MoreWe are delighted to announce that Professor Melanie Bahlo joined AGRF’s board. Melanie is a renowned expert in medical biology, with an impressive career dedicated to advancing research in health and ageing. Melanie currently serves as a Professor at the Walter and Eliza Hall Institute (WEHI), where she leads the "Healthy Development and Ageing" theme, underlining her commitment to impactful research in this critical field.
Read MoreAGRF are proud to announce its recent recognition as an Olink® Certified Service Provider.
Read MoreCollaboration Establishes AGRF as Premier Provider of Dovetail's Cutting-Edge Genomic Technologies, Boosting Innovation and Access Across Australia and New Zealand
Read MoreIn an exciting step forward for children’s cancer research, the Australian Cancer Research Foundation (ACRF) has awarded a $2 million grant to Children’s Cancer Institute. The grant will advance the initiation of their Spatial Immune-oncology Research program, aiming to unlock the potential of immunotherapies specifically tailored for childhood cancer. A key partnership with AGRF will introduce our Olink technology for in-depth protein analysis, unlocking new possibilities in paediatric cancer research.
Read MoreAGRF is thrilled to announce the introduction of the Olink Explore high throughput platform to our fleet of cutting-edge technologies, bringing the most advanced proteomic technology to Australia and positioning AGRF as a truly multi-omics destination. This strategic move promises to be a game changer in precision medicine, offering researchers a full multi-omics profile of patient and biobank samples.
Read MoreWe're delighted to announce the appointment of Associate Prof. Vanessa (Ness) Tyrrell to the AGRF board. With over 30 years of expertise in genetic testing and a leadership role in the Zero Childhood Cancer National Precision Medicine Program, Ness brings invaluable experience to enrich our Board’s expertise.
Read MoreWe are thrilled to announce that Dr Benjamin Nash has been named as the recipient of the 2023 PacBio ANZ Revio HiFi SMRT Grant! Ben’s project, titled “Precision medicine in inherited retinal dystrophies (IRDs) using long read sequencing.” has captured our attention and admiration and we are delighted to be working with Ben and his team.
Read MoreAs we conclude National Science Week 2023, we are delighted to share a truly exceptional achievement that resonates with the spirit of innovation and inspiration. It is with great excitement that we can reveal the news of Dr Kirk Jensen’s selection into NASA’s prestigious STAR (Space Technology Advanced Research) program. This achievement marks a significant milestone in Kirk’s career, reflecting his brilliance and commitment to excellence in Single Cell and Spatial Biology.
Read MoreMedia Release
The latest in highly accurate long-read sequencing technology has arrived at AGRF. First in Australia and the region, the PacBio Revio offers dramatic improvements in the production of high precision HiFi reads at lower sequencing costs and symbolises an important shift in the acceleration of biological understanding.
“The answers people are looking for are often locked up deep inside of our genomes. This system will enable scientists to tackle their biggest questions, no matter what fields they are exploring. We are thrilled to be the first in Australia to implement the Revio and support clients at an affordability that has not been possible before.”
Dr Cath Moore, Chief Scientific Officer - AGRF
Read MoreMedia Release
Australian Genome Research Facility (AGRF) has expanded its state-of-the-art genomic sequencing line-up with the arrival of Illumina’s most powerful sequencing instrument to-date, the NovaSeq™ X Plus. AGRF is Australia’s premier genomics service provider, proudly supporting the genomics community in Australia and beyond for the past 25 years.
“We continue to provide access to cutting edge technology for our clients and partners and are thrilled to be the first in Australia and amongst the first in the world to introduce this incredible system” says AGRF Chief Executive Officer, Joe Baini.
Read More
AGRF respectfully acknowledge the Aboriginal and Torres Straight Islander people as the Traditional Owners of the land on which we work and live, and we pay our respects to their Elders past and present.
We respect and recognise their continuing connection to Country and land, water and community.
AGRF Ltd.
ABN - 63 097 086 292
Please note: We do not offer genetic services or consultation to the public. Our genetic sequencing solutions are available exclusively through healthcare providers and research partners.
